The clinical course and outcome of 5 adult @entity1 who underwent orthotopic liver transplantation (OLT) and developed @entity2826 ( @entity2826 ) is reported. From October 1986 to July 2000, a total of 459 @entity1 underwent 499 OLTs at our hospital. The immunosuppressive regimen consisted of @entity205 , @entity500 , @entity229 , and antithymocyte globulin. @entity1140 was administered only in selected @entity1 . Five @entity1 developed @entity2826 , and the pathological diagnosis was established months 9 to 23 after OLT. Four of 5 @entity1 died of @entity2826 , surviving 0 to 6 months after pathological diagnosis. The fifth @entity1 , with @entity2826 confined to the skin, is disease free 6 months after diagnosis. All @entity1 were treated with reduction of immunosuppressive therapy and/or chemotherapy. Retrospective molecular investigation by polymerase chain reaction for @entity1 herpesvirus type 8 DNA detected specific viral sequences in histological specimens of tissues involved by @entity2826 . In our experience with adult liver transplant recipients, we registered a slightly lower prevalence of @entity2826 compared with other reported data, but observed a high rate of graft involvement and mortality.

XXXX in liver transplant recipients: morphological and clinical description.

@entity1 :: ('9606', 'Species') :: ['human', 'patients', 'patient'] @entity2826 :: ('MESH:D012514', 'Disease') :: ["Kaposi's sarcoma", 'KS'] @entity500 :: ('MESH:D001379', 'Chemical') :: ['azathioprine'] @entity229 :: ('MESH:D011241', 'Chemical') :: ['prednisone'] @entity205 :: ('MESH:D016572', 'Chemical') :: ['cyclosporine'] @entity1140 :: ('MESH:D016559', 'Chemical') :: ['Tacrolimus']
@entity2826 :: (MESH:D012514,Disease) :: ['Kaposi's sarcoma']
